Position in XNCR
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$1,484,420
-$3,703,792 QoQ
Shares Held
92,200
-78.6% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#61
of 208 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Erste Asset Management GmbH holds $553,204,959 across 68 Biotechnology names. XNCR ranks #44 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,154,900 | $79,968,339 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
110,210 | $59,177,259 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
2,568,945 | $46,163,941 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
76,558 | $38,028,654 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
834,000 | $29,515,260 | |
| 6 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
2,536,939 | $25,141,065 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,716 | $24,140,974 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
205,000 | $23,999,350 |
All Filings in XNCR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,484,420 | 92,200 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $5,188,212 | 430,200 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $7,351,862 | 480,200 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $4,459,746 | 380,200 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,988,372 | 380,200 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,045,328 | 380,200 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,093,556 | 352,200 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $7,082,742 | 352,200 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,326,406 | 334,200 | Shares | Sole | 2024-11-26 | |
| 2024-03-31 | $7,395,846 | 334,200 | Shares | Sole | 2024-11-26 | |
| 2023-12-31 | $7,095,066 | 334,200 | Shares | Sole | 2024-11-26 | |
| 2023-09-30 | $4,517,630 | 224,200 | Shares | Sole | 2024-11-26 | |
| 2023-06-30 | $5,598,274 | 224,200 | Shares | Sole | 2024-11-26 | |
| 2023-03-31 | $5,918,258 | 212,200 | Shares | Sole | 2024-11-26 | |
| 2022-12-31 | $5,525,688 | 212,200 | Shares | Sole | 2024-11-26 | |
| 2022-09-30 | $4,473,756 | 172,200 | Shares | Sole | 2024-11-26 | |
| 2022-06-30 | $4,713,114 | 172,200 | Shares | Sole | 2024-11-26 | |
| 2022-03-31 | $4,594,296 | 172,200 | Shares | Sole | 2024-11-25 | |
| 2021-12-31 | $6,908,664 | 172,200 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $5,297,452 | 162,200 | Shares | Sole | 2024-11-25 | |
| 2021-06-30 | $5,007,948 | 145,200 | Shares | Sole | 2024-11-25 | |
| 2021-03-31 | $5,778,652 | 134,200 | Shares | Sole | 2024-11-25 | |
| 2020-12-31 | $5,855,146 | 134,200 | Shares | Sole | 2024-11-25 | |
| 2020-09-30 | $5,205,618 | 134,200 | Shares | Sole | 2024-11-25 | |
| 2020-06-30 | $4,346,738 | 134,200 | Shares | Sole | 2024-11-22 | |
| 2020-03-31 | $3,860,496 | 129,200 | Shares | Sole | 2024-11-22 | |
| No filing history on record for this holder in this stock. | ||||||